Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Metformin for Preventing Frailty in High-risk Older Adults

Authors not listed

The University of Texas Health Science Center at San Antonio · 2016

Abstract

Frailty is a geriatric syndrome which leads to poor health outcomes in older adults, such as falls, disability, hospitalization, institutionalization, and death. Due to the dramatic growth in the U.S. aging population and the health care costs associated with frailty (estimated at more than $18 billion per year), frailty is a major health care problem. There has been little research into potential pharmacologic interventions that would delay or reduce the incidence of frailty. Thus, the major goal of this study is to test metformin as a novel intervention for the prevention of frailty. The investigators propose that diabetes/insulin resistance and inflammation are major contributors to frailty, and that the use of metformin to modulate diabetes/insulin resistance and inflammation will prevent and/or ameliorate the progression of frailty.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-06 MST

Cite this

APA
Anonymous. (2016). Metformin for Preventing Frailty in High-risk Older Adults. <em>The University of Texas Health Science Center at San Antonio</em>. https://clinicaltrials.gov/study/NCT02570672
Vancouver
Anonymous. Metformin for Preventing Frailty in High-risk Older Adults. The University of Texas Health Science Center at San Antonio. 2016.
BibTeX
@misc{anon2016Metfor, title = {Metformin for Preventing Frailty in High-risk Older Adults}, author = {Anonymous}, journal = {The University of Texas Health Science Center at San Antonio}, year = {2016}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings